Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE6D | O43924 | 1/20 | 0.42 |
| ▸ | GALR3 | O60755 | 1/20 | 0.39 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.35 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.35 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23476536 | 0.95 | PDE6D (0.45) | PDE6DGALR3HTR4LMNAALDH1A1 | |
| SCHEMBL23516345 | 0.95 | GALR3 (0.43) | PDE6DGALR3HTR4LMNAALDH1A1 | |
| SCHEMBL19843149 | 0.93 | LMNA (0.39) | PDE6DGALR3HTR4LMNAALDH1A1 | |
| SCHEMBL19843091 | 0.93 | LMNA (0.37) | PDE6DGALR3HTR4LMNAALDH1A1 | |
| SCHEMBL19843328 | 0.91 | TYMS (0.41) | PDE6DGALR3HTR4LMNAALDH1A1 | |
| SCHEMBL19843303 | 0.90 | NR1H2 (0.41) | GALR3HTR4LMNAALDH1A1NPSR1 | |
| SCHEMBL19843434 | 0.90 | ALDH1A1 (0.37) | GALR3HTR4LMNAALDH1A1NPSR1 | |
| SCHEMBL23516340 | 0.90 | GALR3 (0.45) | PDE6DGALR3HTR4LMNAALDH1A1 | |
| SCHEMBL19843365 | 0.90 | TYMS (0.38) | PDE6DGALR3HTR4LMNAALDH1A1 | |
| SCHEMBL19843084 | 0.90 | ALDH1A1 (0.35) | PDE6DGALR3HTR4LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494112-B1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2022-04-20 | — | — | EP | disclosed |
| US-11276825-B2 | Organic molecules for use in organic devices | CYNORA GMBH (DE) | 2022-03-15 | — | — | US | disclosed |
| US-20210184134-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
| US-20210171501-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| WO-2018024725-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171501-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | L1CAM, OR10J3, AOX1 | PDE6D 923/4885GALR3 1445/4885HTR4 3742/4885 |
| US-20210184134-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES | CHRM1, C1S, DNMT3L | PDE6D 611/4885GALR3 367/4885HTR4 475/4885 |
| US-11276825-B2 | Organic molecules for use in organic devices | AOX1, OR10J3, L1CAM | PDE6D 162/4885GALR3 990/4885HTR4 2843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.